Blog

RSS Feed
Posted by Michael Wonder on 10 Mar 2023

Will NZ neurological drug Trofinetide for Rett syndrome get US FDA approval and make history?

10 March 2023 - Kiwi scientists may be about to make New Zealand history, with a breakthrough treatment on the ...

Read more →
Posted by Michael Wonder on 23 Mar 2016

Action receives approval for Uptravi (selexipag) for the treatment of pulmonary arterial hypertension in Australia and New Zealand

22 March 2016 - Actelion announced today that the Therapeutic Goods Administration (TGA) of Australia and the New Zealand Medicines and ...

Read more →
Posted by Michael Wonder on 08 Mar 2016

Specialized Therapeutics grants sublicense for anti-emetic products to Mundipharma

7 March 2016 - Under the terms of the arrangement, Specialized Therapeutics grants Mundipharma exclusive marketing, promotion, distribution and sales rights ...

Read more →